Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 358
1.
PLoS One ; 19(5): e0301341, 2024.
Article En | MEDLINE | ID: mdl-38753666

The deficiency of clinically specific biomarkers has made it difficult to achieve an accurate diagnosis of temporomandibular joint osteoarthritis (TMJ-OA) and the insufficient comprehension of the pathogenesis of the pathogenesis of TMJ-OA has posed challenges in advancing therapeutic measures. The combined use of metabolomics and transcriptomics technologies presents a highly effective method for identifying vital metabolic pathways and key genes in TMJ-OA patients. In this study, an analysis of synovial fluid untargeted metabolomics of 6 TMJ-OA groups and 6 temporomandibular joint reducible anterior disc displacement (TMJ-DD) groups was conducted using liquid and gas chromatography mass spectrometry (LC/GC-MS). The differential metabolites (DMs) between TMJ-OA and TMJ-DD groups were analyzed through multivariate analysis. Meanwhile, a transcriptomic dataset (GSE205389) was obtained from the GEO database to analyze the differential metabolism-related genes (DE-MTGs) between TMJ-OA and TMJ-DD groups. Finally, an integrated analysis of DMs and DE-MTGs was carried out to investigate the molecular mechanisms associated with TMJ-OA. The analysis revealed significant differences in the levels of 46 DMs between TMJ-OA and TMJ-DD groups, of which 3 metabolites (L-carnitine, taurine, and adenosine) were identified as potential biomarkers for TMJ-OA. Collectively, differential expression analysis identified 20 DE-MTGs. Furthermore, the integration of metabolomics and transcriptomics analysis revealed that the tricarboxylic acid (TCA) cycle, alanine, aspartate and glutamate metabolism, ferroptosis were significantly enriched. This study provides valuable insights into the metabolic abnormalities and associated pathogenic mechanisms, improving our understanding of TMJOA etiopathogenesis and facilitating potential target screening for therapeutic intervention.


Metabolomics , Osteoarthritis , Temporomandibular Joint Disorders , Transcriptome , Humans , Osteoarthritis/metabolism , Osteoarthritis/genetics , Metabolomics/methods , Male , Female , Temporomandibular Joint Disorders/metabolism , Temporomandibular Joint Disorders/genetics , Adult , Temporomandibular Joint/metabolism , Temporomandibular Joint/pathology , Gene Expression Profiling , Biomarkers/metabolism , Synovial Fluid/metabolism , Gas Chromatography-Mass Spectrometry , Middle Aged
2.
Front Immunol ; 15: 1335181, 2024.
Article En | MEDLINE | ID: mdl-38529278

Introduction: Temporomandibular joint (TMJ) osteoarthritis (OA) is a common TMJ degenerative disease with an unclear mechanism. Synovial fluid (SF), an important component of TMJ, contains various proteins and metabolites that may directly contribute to OA. The present study aimed to investigate the influence of SF in TMJOA at the metabolite level. Methods: Untargeted and widely targeted metabolic profiling were employed to identify metabolic changes in SF of 90 patients with different TMJOA grades according to TMJ magnetic resonance imaging. Results: A total 1498 metabolites were detected. Most of the metabolites were amino acids and associated metabolites, benzene and substituted derivatives, and lipids. Among patients with mild, moderate and severe TMJOA, 164 gradually increasing and 176 gradually decreasing metabolites were identified, indicating that biosynthesis of cofactors, choline metabolism, mineral absorption and selenocompound metabolism are closely related to TMJOA grade. Combined metabolomics and clinical examination revealed 37 upregulated metabolites and 16 downregulated metabolites in patients with pain, of which 19 and 26 metabolites were positively and negatively correlated, respectively, with maximum interincisal opening. A model was constructed to diagnose TMJOA grade and nine biomarkers were identified. The identified metabolites are key to exploring the mechanism of TMJOA. Discussion: In the present study, a metabolic profile was constructed and assessed using a much larger number of human SF samples from patients with TMJOA, and a model was established to contribute to the diagnosis of TMJOA grade. The findings expand our knowledge of metabolites in human SF of TMJOA patients, and provide an important basis for further research on the pathogenesis and treatment of TMJOA.


Osteoarthritis , Temporomandibular Joint Disorders , Humans , Synovial Fluid/metabolism , Temporomandibular Joint/pathology , Osteoarthritis/metabolism , Temporomandibular Joint Disorders/metabolism , Temporomandibular Joint Disorders/pathology , Metabolomics/methods
3.
J Oral Rehabil ; 51(6): 1025-1033, 2024 Jun.
Article En | MEDLINE | ID: mdl-38475974

BACKGROUND: Longitudinal intervention studies on treatment options in temporomandibular dysfunction (TMD) including self reports and salivary biomarkers of stress are rare and the exact therapeutic function of occlusal splints widely unknown. METHODS: We examined the therapeutic effects of a Michigan splint with occlusal relevance in patients with TMD using a placebo-controlled, delayed-start design. Two intervention groups received a Michigan splint, while one of them had a placebo palatine splint for the first 3 weeks. We collected pain intensities (at rest and after five occlusal movements), salivary measures associated with stress (cortisol and alpha-amylase) and self-reported psychological distress (stress, anxiety, catastrophizing) at baseline and 3 and 7 weeks after onset of intervention. RESULTS: At baseline, we observed increased pain intensity and psychological distress in TMD patients compared to 11 matched healthy controls. Baseline anxiety was linked to movement pain intensity through stress. Over therapy reductions in pain intensity and morning cortisol were more pronounced in those patients starting immediately with the Michigan splint, while psychological distress decreased similarly in both groups. CONCLUSION: Our results suggest that perceived stress plays a role for the association between anxiety and TMD pain and underlines the need for an interdisciplinary perspective on the pathogenesis and therapy of TMD in a setting where psychotherapeutic knowledge is still scarce or rarely applied.


Biomarkers , Hydrocortisone , Occlusal Splints , Pain Measurement , Saliva , Stress, Psychological , Temporomandibular Joint Disorders , Humans , Female , Temporomandibular Joint Disorders/psychology , Temporomandibular Joint Disorders/therapy , Temporomandibular Joint Disorders/physiopathology , Temporomandibular Joint Disorders/metabolism , Temporomandibular Joint Disorders/complications , Adult , Male , Saliva/chemistry , Saliva/metabolism , Biomarkers/analysis , Biomarkers/metabolism , Stress, Psychological/therapy , Stress, Psychological/metabolism , Hydrocortisone/metabolism , Hydrocortisone/analysis , Treatment Outcome , Facial Pain/therapy , Facial Pain/psychology , Facial Pain/physiopathology , Facial Pain/metabolism , Middle Aged , Young Adult , alpha-Amylases/metabolism , alpha-Amylases/analysis
4.
Cell Mol Neurobiol ; 44(1): 22, 2024 Feb 16.
Article En | MEDLINE | ID: mdl-38363424

Calcitonin gene-related peptide (CGRP) is synthesized and secreted by trigeminal ganglion neurons, and is a key neuropeptide involved in pain and immune regulation. This study investigates the expression of CGRP in the trigeminal ganglion (TG) and its regulatory role in the polarization of macrophages in rats with temporomandibular arthritis. A rat model of temporomandibular arthritis was established using CFA. Pain behavior was then observed. Temporomandibular joint (TMJ) and the TG were collected, and immunohistochemistry, immunofluorescence (IF) staining, and RT-qPCR were used to examine the expression of CGRP and macrophage-related factors. To investigate the impact of CGRP on macrophage polarization, both CGRP and its antagonist, CGRP 8-37, were separately administered directly within the TG. Statistical analysis revealed that within 24 h of inducing temporomandibular arthritis using CFA, there was a significant surge in CD86 positive macrophages within the ganglion. These macrophages peaked on the 7th day before beginning their decline. In this context, it's noteworthy that administering CGRP to the trigeminal ganglion can prompt these macrophages to adopt the M2 phenotype. Intriguingly, this study demonstrates that injecting the CGRP receptor antagonist (CGRP 8-37) to the ganglion counteracts this shift towards the M2 phenotype. Supporting these in vivo observations, we found that in vitro, CGRP indeed fosters the M2-type polarization of macrophages. CGRP can facilitate the conversion of macrophages into the M2 phenotype. The phenotypic alterations of macrophages within the TG could be instrumental in initiating and further driving the progression of TMJ disorders.


Calcitonin Gene-Related Peptide , Macrophages , Temporomandibular Joint Disorders , Trigeminal Ganglion , Animals , Rats , Calcitonin Gene-Related Peptide/metabolism , Macrophages/metabolism , Pain/metabolism , Temporomandibular Joint Disorders/metabolism , Trigeminal Ganglion/metabolism
5.
Dev Biol ; 507: 1-8, 2024 Mar.
Article En | MEDLINE | ID: mdl-38114053

The temporomandibular joint (TMJ), composed of temporal fossa, mandibular condyle and a fibrocartilage disc with upper and lower cavities, is the biggest synovial joint and biomechanical hinge of the craniomaxillofacial musculoskeletal system. The initial events that give rise to TMJ cavities across diverse species are not fully understood. Most studies focus on the pivotal role of molecules such as Indian hedgehog (Ihh) and hyaluronic acid (HA) in TMJ cavitation. Although biologists have observed that mechanical stress plays an irreplaceable role in the development of biological tissues and organs, few studies have been concerned with how mechanical stress regulates TMJ cavitation. Based on the evidence from human or other animal embryos today, it is implicated that mechanical stress plays an essential role in TMJ cavitation. In this review, we discuss the relationship between mechanical stress and TMJ cavitation from evo-devo perspectives and review the clinical features and potential pathogenesis of TMJ dysplasia.


Hedgehog Proteins , Temporomandibular Joint Disorders , Animals , Humans , Stress, Mechanical , Hedgehog Proteins/metabolism , Temporomandibular Joint/metabolism , Temporomandibular Joint/pathology , Mandibular Condyle/metabolism , Mandibular Condyle/pathology , Temporomandibular Joint Disorders/metabolism , Temporomandibular Joint Disorders/pathology
6.
Exp Biol Med (Maywood) ; 248(17): 1500-1506, 2023 09.
Article En | MEDLINE | ID: mdl-36941805

Patients with temporomandibular dysfunction (TMD) usually suffer from pathology or malpositioning of the temporomandibular joint (TMJ) disk, leading to the degenerative lesion of condyles. Kartogenin can promote the repair of damaged cartilage. This study aimed to explore whether intra-articular injection of kartogenin could alleviate the TMJ injury induced by type II collagenase. We measured the head withdrawal threshold and found that kartogenin alleviated the pain around TMD induced by type II collagenase. We observed the morphology of the condylar surface and found that kartogenin protected the integration of the condylar surface. We analyzed the density of the subchondral bone and found that kartogenin minimized the damage of TMJ injury to the subchondral bone. We next explored the histological changes and found that kartogenin increased the thickness of the proliferative layer and more collagen formation in the superficial layer. Then, to further ensure whether kartogenin promotes cell proliferation in the condyle, we performed immunohistochemistry of proliferating cell nuclear antigen (PCNA). The ratio of PCNA-positive cells was significantly increased in the kartogenin group. Next, immunofluorescence of TGF-ß1 and SMAD3 was performed to reveal that kartogenin activated the TGF-ß/SMAD pathway in the proliferative layer. In conclusion, kartogenin may have a therapeutic effect on TMJ injury by promoting cell proliferation in cartilage and subchondral bone. Kartogenin may be promising as an intra-articular injection agent to treat TMD.


Cartilage, Articular , Osteoarthritis , Temporomandibular Joint Disorders , Humans , Rats , Animals , Proliferating Cell Nuclear Antigen/metabolism , Proliferating Cell Nuclear Antigen/pharmacology , Proliferating Cell Nuclear Antigen/therapeutic use , Transforming Growth Factor beta/metabolism , Mandibular Condyle , Temporomandibular Joint Disorders/drug therapy , Temporomandibular Joint Disorders/metabolism , Temporomandibular Joint Disorders/pathology , Chondrocytes/metabolism , Cartilage, Articular/metabolism , Osteoarthritis/metabolism , Temporomandibular Joint/metabolism , Temporomandibular Joint/pathology , Collagenases/metabolism , Collagenases/pharmacology , Collagenases/therapeutic use
7.
Eur J Histochem ; 66(3)2022 Jun 21.
Article En | MEDLINE | ID: mdl-35726537

HMGB1 is a highly conserved nuclear protein that is rapidly released into the extracellular environment during infection or tissue damage. In osteoarthritis, HMGB1 acts as a pro-inflammatory cytokine inducing a positive feedback loop for synovial inflammation and cartilage degradation. The aim of this study was to explore the role of HMGB1 in inflammation and catabolism of temporomandibular joint osteoarthritis (TMJOA) and whether inhibition of HMGB1 affects TMJOA. Human synovial fibroblasts were incubated with HMGB1, the expression of pro-inflammatory cytokines and catabolic mediators were measured by Western blot and ELISA. NF-κB signaling pathway involvement was studied by the NF-κB inhibitor and detected by Western blotting and immunofluorescence staining. TMJOA was induced by an injection of Complete Freund's adjuvant (CFA) into anterosuperior compartment of rat's joint. An anti-HMGB1 antibody was used to assess the effect to HMGB1 in the synovium and cartilage of the CFA-induced TMJOA rats by H&E, Safranin O, Masson trichrome staining, immunohistochemistry and immunofluorescence. HMGB1 markedly increased the production of MMP13, ADAMTS5, IL-1ß and IL-6 through activating NF-κB signaling pathway in human synovial fibroblasts. In vivo, application of the HMGB1 neutralizing antibody effectively ameliorated the detrimental extent of TMJOA. Furthermore, the HMGB1 neutralizing antibody reduced the expression of NF-κB, pro-inflammatory cytokines and catabolic mediators in the synovium and cartilage of CFA-induced TMJOA rats. HMGB1 inhibition alleviates TMJOA by reducing synovial inflammation and cartilage catabolism possibly through suppressing the NF-κB signaling pathway and may become a therapeutic method against TMJOA.


HMGB1 Protein , Osteoarthritis , Temporomandibular Joint Disorders , Animals , Antibodies, Neutralizing/pharmacology , Cytokines/metabolism , Freund's Adjuvant/pharmacology , HMGB1 Protein/metabolism , Humans , Inflammation , NF-kappa B/metabolism , Osteoarthritis/metabolism , Rats , Signal Transduction , Temporomandibular Joint Disorders/metabolism
8.
J Craniomaxillofac Surg ; 50(5): 432-438, 2022 May.
Article En | MEDLINE | ID: mdl-35491326

The aim of this study was to investigate the effect various mediators in synovial fluid (SF) on the pathogenesis of temporomandibular disorders (TMD) and to evaluate the relationship between clinical and radiological features of temporomandibular joint (TMJ) diseases. Patients who had received SF sample during arthrocentesis because of TMD were included in this study. Clinical and radiological records were evaluated retrospectively. Enzyme-Linked ImmunoSorbent Assay (ELISA) method was used for analysis of aggrecan, adiponectin, resistin, apelin, Vascular Endothelial Growth Factor (VEGF) and Prostaglandin E2 (PGE2) in SFs. 59 joints of 41 patients were included in the study. Anterior disc displacement with reduction (ADDwR) was detected in 22 joints, anterior disc displacement without reduction (ADDwoR) was detected in 29 joints and osteoarthritis (OA) in 8. In OA group, PGE2 level was significantly higher than the other groups (p = 0.029). Aggrecan and PGE2 levels were statistically higher in joints with localized pain (p = 0.030, p = 0.029). The aggrecan level was statistically significant higher in patients who had degenerative changes in radiological examinations (p = 0.044). Resistin was correlated with PGE2 and aggrecan (p = 0.011), and apelin showed positive correlation with VEGF (p˂0.001). The detection of aggrecan and adipokines in SF may be a precursor of degenerative joint disease and it should be taken into account that the presence of localized pain in the joint area may be an early sign of degenerative changes.


Joint Dislocations , Temporomandibular Joint Disorders , Adipokines , Aggrecans , Apelin , Dinoprostone , Humans , Joint Dislocations/pathology , Pain , Resistin , Retrospective Studies , Synovial Fluid/metabolism , Temporomandibular Joint/pathology , Temporomandibular Joint Disorders/metabolism , Vascular Endothelial Growth Factor A
9.
J Tissue Eng Regen Med ; 16(7): 591-604, 2022 07.
Article En | MEDLINE | ID: mdl-35357772

Temporomandibular joint disorders (TMDs) range from gross anatomic deformities of the disc and hard tissue to functional disturbances. Traditional treatment of TMDs includes physical therapy, use of appliances, pharmacological, surgical and psychological interventions. However, during the late stage of TMDs, conventional management often results in inadequate relief of symptoms. Stem cell-based tissue regeneration has been studied extensively in joint regeneration, including the Temporomandibular Joint (TMJ). This study aims to review the potential of various human stem cells (HSC) for the regeneration of the TMJ. In vitro studies using human mesenchymal stem cells cultured under different conditions to evaluate regeneration of TMJ related structures were searched on PubMed, EMBASE, Cochrane, and Web of Science up to March 2020. In vitro studies utilized several different types of stem cells under varying conditions. Increased osteogenesis and/or chondrogenesis were noted with stem cell interventions compared to control groups on Alkaline Phosphatase (ALP) activity, Col-I, Col-II, Col-X, RUNX2, LPL, and Aggrecan mRNA expression. This review emphasizes the potential of stem cell therapies in the regeneration of TMJ-related structures. However, further in vivo studies are required to evaluate the efficacy and safety of these therapies in humans.


Temporomandibular Joint Disc , Temporomandibular Joint Disorders , Chondrogenesis , Humans , Stem Cells , Temporomandibular Joint/metabolism , Temporomandibular Joint Disorders/metabolism , Temporomandibular Joint Disorders/therapy
10.
Histol Histopathol ; 37(5): 415-422, 2022 May.
Article En | MEDLINE | ID: mdl-35194774

BACKGROUND: Temporomandibular joint osteoarthritis (TMJOA) and knee osteoarthritis (knee OA) are two kinds of common osteoarthritis (OA) that are characterized by chronic degeneration of soft and hard tissues around joints. Their gender and age differences suggest that there are similarities and differences between the pathogenic mechanisms of TMJOA and knee OA. OBJECTIVE: To review recent studies on the effect of estrogen on TMJOA and knee OA, and summarize their possible pathogenesis and molecular mechanisms. SOURCES: Articles up to present reporting the relationship of estrogen and TMJOA or knee OA are included. An extensive electronic search was conducted of databases including PubMed, Web of science core collection. CONCLUSION: According to epidemiological investigations, TMJOA primarily happens to females of puberty and childbearing age, while knee OA mainly affects postmenopausal women. Epidemiological investigation and experimental research suggest that estrogen may have a different effect on TMJ and on knee. Though estrogen regulates TMJOA and knee OA via estrogen-related receptors (ERR), their pathogenesis and pathway of estrogen regulation are different. To find out the accurate regulation of estrogen on TMJOA and knee OA, specific pathways and molecular mechanisms still need further exploration.


Osteoarthritis, Knee , Temporomandibular Joint Disorders , Estrogens , Female , Humans , Receptors, Estrogen , Temporomandibular Joint/metabolism , Temporomandibular Joint Disorders/metabolism
11.
Ann N Y Acad Sci ; 1511(1): 210-227, 2022 05.
Article En | MEDLINE | ID: mdl-35188225

Mandibular deviation affects the biomechanical environment of the temporomandibular joint (TMJ) and causes thinning of cartilage on the deviated side. We aimed to evaluate, using a rat model, the effect of mandibular functional deviation on the TMJ in relation to the functional roles of integrin ß family members. The effects of experimental functional deviation on the TMJ of 6-week-old Sprague-Dawley female rats, randomly assigned to control (n = 42) and experimental groups (n = 42), were evaluated at 3 days and 1, 2, 4, and 8 weeks by histological staining, immunofluorescence, real-time quantitative polymerase chain reaction, and micro-computed tomography. The results showed that the experimental functional shift changed the shape of condyles, thinned the cartilage, and increased the proportion of the hypertrophic layer on the deviated sides of condyles. In addition, the extracellular matrix of the condyle cartilage exhibited degradation at 1 week and subchondral trabecular bone was lost at 4 and 8 weeks. Osteoarthritis (OA)-like changes occurred in the left and right condyles of rats in the experimental group and were aggravated over time. Integrin ß family expression, especially integrin ß2 , was altered from week 1, possibly related to the OA-like changes. These data may provide insight into the onset of TMJ OA.


Cartilage, Articular , Osteoarthritis , Temporomandibular Joint Disorders , Animals , Cartilage, Articular/pathology , Disease Models, Animal , Female , Humans , Integrins/metabolism , Mandibular Condyle/diagnostic imaging , Mandibular Condyle/metabolism , Mandibular Condyle/pathology , Osteoarthritis/pathology , Rats , Rats, Sprague-Dawley , Temporomandibular Joint/metabolism , Temporomandibular Joint/pathology , Temporomandibular Joint Disorders/etiology , Temporomandibular Joint Disorders/metabolism , Temporomandibular Joint Disorders/pathology , X-Ray Microtomography/adverse effects
12.
Int J Mol Sci ; 23(3)2022 Jan 31.
Article En | MEDLINE | ID: mdl-35163584

Application of mesenchymal stem cells (MSC) in regenerative therapeutic procedures is becoming an increasingly important topic in medicine. Since the first isolation of dental tissue-derived MSC, there has been an intense investigation on the characteristics and potentials of these cells in regenerative dentistry. Their multidifferentiation potential, self-renewal capacity, and easy accessibility give them a key role in stem cell-based therapy. So far, several different dental stem cell types have been discovered and their potential usage is found in most of the major dental medicine branches. These cells are also researched in multiple fields of medicine for the treatment of degenerative and inflammatory diseases. In this review, we summarized dental MSC sources and analyzed their treatment modalities with particular emphasis on temporomandibular joint osteoarthritis (TMJ OA).


Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells/metabolism , Osteoarthritis , Regenerative Medicine , Temporomandibular Joint Disorders , Temporomandibular Joint/metabolism , Tooth/metabolism , Humans , Osteoarthritis/metabolism , Osteoarthritis/therapy , Temporomandibular Joint Disorders/metabolism , Temporomandibular Joint Disorders/therapy
13.
J Dent Res ; 101(3): 312-322, 2022 03.
Article En | MEDLINE | ID: mdl-34515572

In this study, we investigate harnessing fibrocartilage stem cell (FCSC) capacities by regulating tumor necrosis factor α (TNF-α) signaling for cartilage repair in temporomandibular joint osteoarthritis (TMJOA). Stem cell specifics for FCSCs were characterized in the presence of TNF-α. Etanercept as a TNF-α inhibitor and BAY 11-7082 as an Nf-κB inhibitor were used to study TNF-α regulation of FCSCs. Lineage tracing was performed in Gli1-CreERT+;Tmfl/fl mice when etanercept (1 mg/kg, every 3 d) or isometric vehicle was subcutaneously injected to trace specific changes in FCSCs. Surgically induced TMJOA Sprague-Dawley rats were generated with BAY 11-7082 (5 mg/kg, every 3 d) or vehicle subcutaneous injection to investigate the functional role of TNF-α/Nf-κB in TMJOA. Anterior disc displacement (ADD) rabbits were used to analyze the therapeutic effect of etanercept as a TMJOA intra-articular treatment with etanercept (0.02 mg in 100 µL, every 2 wk) or isometric vehicle. In vitro, TNF-α inhibited proliferation of FCSCs and increased FCSC apoptosis. TNF-α activation interfered with osteogenic and chondrogenic differentiation of FCSCs, while etanercept could partially recover FCSC specificity from TNF-α. FCSC lineage tracing in Gli1-CreERT+;Tmfl/fl mice showed that the chondrogenic capacity of Gli1+ cell lineage was markedly suppressed in osteoarthritis cartilage, the phenotype of which could be significantly rescued by etanercept. Specifically blocking the Nf-κB pathway could significantly weaken the regulatory effect of TNF-α on FCSC specificity in vitro and in TMJOA rats in vivo. Finally, intra-articular etanercept treatment efficiently rescued TMJ cartilage degeneration and growth retardation in ADD rabbits. Inhibition of TNF-α signaling reduced Nf-κB transcripts and recovered FCSC specificities. In vivo, etanercept treatment effectively rescued the osteoarthritis phenotype in TMJOA mice and ADD rabbits. These data suggest a novel therapeutic mechanism whereby TNF-α/Nf-κB inhibition promotes FCSC chondrogenic capacity for cartilage transformation in TMJOA.


Fibrocartilage , NF-kappa B , Osteoarthritis , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Chondrocytes/drug effects , Chondrocytes/metabolism , Etanercept/pharmacology , Etanercept/therapeutic use , Fibrocartilage/drug effects , Fibrocartilage/metabolism , Fibrocartilage/pathology , Mice , NF-kappa B/metabolism , Osteoarthritis/drug therapy , Osteoarthritis/pathology , Rabbits , Rats , Rats, Sprague-Dawley , Stem Cells/drug effects , Stem Cells/metabolism , Temporomandibular Joint/metabolism , Temporomandibular Joint Disorders/drug therapy , Temporomandibular Joint Disorders/metabolism , Temporomandibular Joint Disorders/pathology , Tumor Necrosis Factor-alpha/metabolism
14.
Biol Pharm Bull ; 44(12): 1801-1809, 2021.
Article En | MEDLINE | ID: mdl-34853262

Temporomandibular disorder (TMD) is an oral dentofacial disease that is related to multiple factors such as disordered dental occlusion, emotional stress, and immune responses. In the past decades, tumor necrosis factor-alpha (TNF-α), a pleiotropic cytokine, has provided valuable insight into the pathogenesis of TMD, particularly in settings associated with inflammation. It is thought that TNF-α participates in the pathogenesis of TMD by triggering immune responses, deteriorating bone and cartilage, and mediating pain in the temporomandibular joint (TMJ). Initially, TNF-α plays the role of "master regulator" in the complex immune network by increasing or decreasing the production of other inflammatory cytokines. Then, the effects of TNF-α on cells, particularly on chondrocytes and synovial fibroblasts, result in pathologic cartilage degradation in TMD. Additionally, multiple downstream cytokines induced by TNF-α and neuropeptides can regulate central sensitization and inflammatory pain in TMD. Previous studies have also found some therapies target TMD by reducing the production of TNF-α or blocking TNF-α-induced pathways. All this evidence highlights the numerous associations between TNF-α and TMD; however, they are currently not fully understood and further investigations are still required for specific mechanisms and treatments targeting specific pathways. Therefore, in this review, we explored general mechanisms of TNF-α, with a focus on molecules in TNF-α-mediated pathways and their potential roles in TMD treatment. In view of the high clinical prevalence rate of TMD and damage to patients' QOL, this review provides adequate evidence for studying links between inflammation and TMD in further research and investigation.


Inflammation/metabolism , Temporomandibular Joint Disorders/metabolism , Tumor Necrosis Factor-alpha/metabolism , Bone and Bones/metabolism , Bone and Bones/pathology , Cartilage/metabolism , Cartilage/pathology , Chondrocytes/metabolism , Cytokines/metabolism , Fibroblasts/metabolism , Humans , Inflammation/complications , Musculoskeletal Pain/metabolism , Temporomandibular Joint/metabolism , Temporomandibular Joint/pathology , Temporomandibular Joint Disorders/etiology , Temporomandibular Joint Disorders/immunology , Temporomandibular Joint Disorders/pathology , Tumor Necrosis Factor-alpha/immunology
15.
Appl Opt ; 60(30): 9295-9302, 2021 Oct 20.
Article En | MEDLINE | ID: mdl-34807064

Structural disorder of the temporomandibular joint (TMJ) is a progressive disease with poor prognosis due to its physiological three-dimensional anatomical position and the complicated relationship among muscles, ligaments, and cartilage. The lack of detection methods for changes in the collagen structure of the TMJ disc makes the diagnosis untimely and unclear. This work aimed to explore the feasibility of using a promising detection technique, second-harmonic generation (SHG), to characterize collagen fibers in a TMJ disc with structural disorders. The TMJ discs with structural disorder were observed using SHG microscopy, and assessment of collagen orientation was conducted by analyzing digitized images. The SHG images were also compared with the scanning electron microscopy images and microscopic images acquired after hematoxylin and eosin and Masson's trichrome staining. The SHG imaging showed that the collagen fibers in diseased TMJ were distributed in a disorderly manner, and pixel intensities in diseased TMJ discs were significantly different from those acquired in healthy TMJs. Moreover, the three dimensions of collagen fibers and dynamic images acquired by SHG nonlinear optical microscopy showed the structural disorder of the collagen fibers in a diseased TMJ. In summary, SHG imaging could provide three-dimensional and quantitative data, with dynamic and critical pathological information for clinical diagnosis, showing its potential value in the diagnosis and evaluation of structural disorders of the TMJ disc.


Collagen/metabolism , Temporomandibular Joint Disorders/metabolism , Animals , Cartilage, Articular , Collagen/ultrastructure , Disease Models, Animal , Male , Microscopy, Electron, Scanning , Rabbits , Second Harmonic Generation Microscopy , Temporomandibular Joint Disorders/diagnostic imaging
16.
Sci Rep ; 11(1): 15695, 2021 08 03.
Article En | MEDLINE | ID: mdl-34344989

Subchondral bone degeneration is the main pathological change during temporomandibular joint (TMJ) osteoarthritis (OA) development. Netrin-1, an axon-guiding factor, might play roles in OA development and pain. The purpose of this study was to investigate the expression of Netrin-1 in TMJ OA and its possible role in the progression of TMJ OA and pain. The synovial fluids of temporomandibular joint disorders (TMDs) patients were collected for Netrin-1 by enzyme linked immunosorbent assay (ELISA). TMJ OA model was built by MIA joint injection, and then the von Frey test, hematoxylin & eosin (H&E) staining, toluidine blue (TB) staining, immunohistochemical (IHC) staining and micro-CT were performed. After induction of osteoclast differentiation of raw264.7 cells, immunofluorescence (IF) was used to detect the Netrin-1 and its receptors on osteoclast membrane. The concentration of Netrin-1 increased in the synovial fluid of TMJ OA patients. After MIA injection to TMJ, the head withdrawal threshold (HWT) was significantly decreased. Microscopically, the structural disorder of subchondral bone was the most obvious at the 2nd week after MIA injection. In addition, Netrin-1 expression increased in the subchondral bone at the 2nd week after MIA injection. In vitro, the expressions of Netrin-1 and its receptor Unc5B were upregulated on the osteoclast membrane. Netrin-1 might be an important regulator during bone degeneration and pain in the process of TMJ OA.


Gene Expression , Netrin-1/genetics , Osteoarthritis/etiology , Temporomandibular Joint Disorders/etiology , Animals , Biomarkers , Cartilage, Articular/pathology , Disease Models, Animal , Humans , Immunohistochemistry , Mice , Netrin-1/metabolism , Osteoarthritis/diagnostic imaging , Osteoarthritis/metabolism , Osteoarthritis/pathology , Osteoclasts/metabolism , Synovial Fluid/metabolism , Temporomandibular Joint Disorders/diagnostic imaging , Temporomandibular Joint Disorders/metabolism , Temporomandibular Joint Disorders/pathology , X-Ray Microtomography
17.
Int J Mol Sci ; 22(14)2021 Jul 09.
Article En | MEDLINE | ID: mdl-34299024

Temporomandibular joint osteoarthritis (TMJ OA) is a low-inflammatory disorder with multifactorial etiology. The aim of this review was to present the current state of knowledge regarding the mechanisms of action and the efficacy of hyaluronic acid (HA), corticosteroids (CS) and platelet-rich plasma (PRP) in the treatment of TMJ OA.: The PubMed database was analyzed with the keywords: "(temporomandibular joint) AND ((osteoarthritis) OR (dysfunction) OR (disorders) OR (pain)) AND ((treatment) OR (arthrocentesis) OR (arthroscopy) OR (injection)) AND ((hyaluronic acid) OR (corticosteroid) OR (platelet rich plasma))". After screening of 363 results, 16 studies were included in this review. Arthrocentesis alone effectively reduces pain and improves jaw function in patients diagnosed with TMJ OA. Additional injections of HA, either low-molecular-weight (LMW) HA or high-molecular-weight (HMW) HA, or CS at the end of the arthrocentesis do not improve the final clinical outcomes. CS present several negative effects on the articular cartilage. Results related to additional PRP injections are not consistent and are rather questionable. Further studies should be multicenter, based on a larger group of patients and should answer the question of whether other methods of TMJ OA treatment are more beneficial for the patients than simple arthrocentesis.


Adrenal Cortex Hormones/therapeutic use , Hyaluronic Acid/therapeutic use , Osteoarthritis/drug therapy , Platelet-Rich Plasma/metabolism , Temporomandibular Joint Disorders/drug therapy , Adolescent , Adrenal Cortex Hormones/pharmacology , Adult , Humans , Hyaluronic Acid/pharmacology , Injections, Intra-Articular , Osteoarthritis/physiopathology , Signal Transduction/drug effects , Signal Transduction/genetics , Temporomandibular Joint Disorders/metabolism , Temporomandibular Joint Disorders/physiopathology
18.
Osteoarthritis Cartilage ; 29(9): 1370-1381, 2021 09.
Article En | MEDLINE | ID: mdl-34126199

OBJECTIVE: To explore the suppressing impact of low phosphorus intake on osteoarthritic temporomandibular joint and the possible mechanisms of nuclear acid injury in the insulted chondrocytes. DESIGN: Chondrocytes were loaded with fluid flow shear stress (FFSS) with or without low phosphorus medium. Seventy-two mice (sampled at 3-, 7- and 11-wk, n = 6) and forty-eight rats (sampled at 12-wks for different testing purpose, n = 6) were applied with unilateral anterior crossbite (UAC) with or without low phosphorus diet. In the FFSS model, the Ca and P content, molecules related to nucleic acid degradation and the mineral-producing responses in chondrocytes were detected. The effect of culture dish stiffness on chondrocytes osteogenic differentiation was measured. In the UAC model, the content of Ca and P in serum were tested. The condylar cartilage ossification and stiffness were detected using micro-CT, scanning electron microscope and atomic force microscope. RESULTS: FFSS induced nucleic acid degradation, Pi accumulation and mineral-producing responses in the cultured chondrocytes, all were alleviated by low P medium. Stiffer dish bottoms promoted the osteogenic differentiation of the cultured chondrocytes. UAC stimulated cartilage degeneration and chondrocytes nucleic acid damage, increased PARP 1 and serum P content, and enhanced ossification and stiffening of the cartilage, all were suppressed by low phosphorus diet (all, P < 0.05). CONCLUSION: Nucleic acid damage takes a role in phosphorus production in osteoarthritic cartilage, contributing to the enhanced mineralization and stiffness of the cartilage that in turn promotes cartilage degradation, which can be alleviated by low phosphorus intake.


Osteoarthritis/prevention & control , Phosphorus, Dietary/administration & dosage , Temporomandibular Joint Disorders/prevention & control , Animals , Female , Mice , Mice, Inbred C57BL , Minerals/metabolism , Osteoarthritis/metabolism , Rats , Rats, Sprague-Dawley , Temporomandibular Joint Disorders/metabolism
19.
Cytokine ; 144: 155551, 2021 08.
Article En | MEDLINE | ID: mdl-33941445

Temporomandibular disorders (TMD) is a chronic pain disease affecting 4-60% of general population. Its suggested etiology includes mechanical overloading to related structures, psychosocial factors, and genetic vulnerability. However, its pathogenesis is yet to be fully understood, especially in cases with a higher level of pain and more associated comorbidities. Recently chronic systemic inflammation and possible autoimmunity has been indicated in several pain conditions as the underlying mechanism of chronicity but this aspect has not been rigorously investigated in TMD. This article focuses on analyzing the levels of cytokines, chemokines, autoantibodies and nonspecific inflammatory markers and comparing their levels according to pain severity and duration in 66 female TMD patients in their 20 s and investigating their association with clinical indices of TMD and comorbidities. The high pain disability group showed decreased range of jaw function and more pain on palpation of capsule areas compared to the low pain disability group. Comorbidities such as anxiety and sleep disturbance were also significantly more prevalent. The level of IL-8 and IgG were significantly higher in the high pain disability group. IL-2, -8, -13, IFN- γ, RANTES, PGE2, and thrombopoietin levels showed a significant effect on indices reflecting jaw function, generalized pain intensity, and health related quality of life. Such results imply that longer pain duration and higher pain intensity is associated with higher levels of systemic inflammation suggesting the possible role of immunologic disturbance as an underlying factor of chronic TMD pain and warranting further investigation for its consideration in diagnosis and treatment.


Autoantibodies/metabolism , Cytokines/metabolism , Temporomandibular Joint Disorders/metabolism , Adult , Anxiety/metabolism , Biomarkers/metabolism , Female , Humans , Inflammation/metabolism , Pain Measurement/methods , Quality of Life , Young Adult
20.
PLoS One ; 16(2): e0246596, 2021.
Article En | MEDLINE | ID: mdl-33635882

The prevalence of temporomandibular joint disorder (TMD) is gradually increasing, and magnetic resonance imaging (MRI) is becoming increasingly common as a modality used to diagnose TMD. Edema and osteonecrosis in the bone marrow of the mandibular condyle have been considered to be precursors of osteoarthritis, but these changes are not evaluated accurately and quantitatively on routine MRI. The iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL-IQ) method, as a cutting-edge MRI technique, can separate fat and water using three asymmetric echo times and the three-point Dixon method. The purpose of this study was to analyze the quantitative fat fraction (FF) in the mandibular condyle head using the IDEAL-IQ method. Seventy-nine people who underwent MRI using IDEAL-IQ were investigated and divided into 1) the control group, without TMD symptoms, and 2) the TMD group, with unilateral temporomandibular joint (TMJ) pain. In both groups, the FF of the condyle head in the TMJ was analyzed by two oral and maxillofacial radiologists. In the TMD group, 29 people underwent cone-beam computed tomography (CBCT) and the presence or absence of bony changes in the condylar head was evaluated. The FF measurements of the condyle head using IDEAL-IQ showed excellent inter-observer and intra-observer agreement. The average FF of the TMD group was significantly lower than that of the control group (p < 0.05). In the TMD group, the average FF values of joints with pain and joints with bony changes were significantly lower than those of joints without pain or bony changes, respectively (p < 0.05). The FF using IDEAL-IQ in the TMJ can be helpful for the quantitative diagnosis of TMD.


Bone Marrow/metabolism , Mandibular Condyle/metabolism , Temporomandibular Joint Disorders/diagnostic imaging , Temporomandibular Joint Disorders/metabolism , Adult , Aged , Cone-Beam Computed Tomography , Female , Humans , Least-Squares Analysis , Magnetic Resonance Imaging , Male , Middle Aged , Water
...